![](/img/cover-not-exists.png)
Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen
Hagen, Patrick, D'Souza, Anita, Hari, Parameswaran, Davila, Omar, Zhang, Mei-Jie, Vesole, David H., Smith, Scott E., Rodriguez, Tulio E., Stiff, Patrick J.Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1811275
Date:
August, 2020
File:
PDF, 1.28 MB
2020